CryoLife, Inc. (CRY)

HEALTH CARE: HEALTH CARE SERVICES
SIC: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

1655 ROBERTS BOULEVARD N W KENNESAW, GA 30144

CryoLife preserves and distributes human tissues and develops, manufactures, and commercializes medical devices for cardiac and vascular applications. Co. distributes human tissue including the CryoValve SG pulmonary heart valve and the CryoPatch SG pulmonary cardiac patch tissue, both processed using its proprietary SynerGraft technology. Co.'s surgical sealants and hemostats include BioGlue Surgical Adhesive, BioFoam Surgical Matrix, and PerClot, an absorbable powdered hemostat. Through its subsidiary Cardiogenesis Corporation, Co. provides treatment of coronary artery disease using a laser console system and single use, fiber-optic handpieces to treat patients with severe angina.

Data as of 2020-06-06
Market Cap952.568 Million Shares Outstanding37.74 Million Avg 30-day Volume199.038 Thousand
P/E Ratio Dividend Yield EPS-0.12
Price/Sales3.462 Price cash flow ratio51.7 Price free cash flow ratio112.7
Book Value7.33 Price to Tangible Book-14.87 Alpha0.01
Short Interest Ratio5.31 % Short Interest to Float3.3 R-squared0.20006
BETA0.975258 52-week High/Low33.0 / 12.63 Stddev0.0936
View SEC Filings from CRY instead.

View recent insider trading info

Funds Holding CRY (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CRY BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

4.7 Thousand total shares from 2 transactions

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

MORGAN HARVEY

  • Director
92,687 2020-06-01 3

MCCALL RONALD D

  • Director
133,433 2020-06-01 5

BEVEVINO DANIEL J

  • Director
115,437 2020-06-01 2

ACKERMAN THOMAS F

  • Director
115,272 2020-06-01 2

SALVESON JON W

  • Director
95,216 2020-06-01 2

BULLOCK JAMES

  • Director
24,023 2020-06-01 2

BURBANK JEFFREY H

  • Director
19,172 2020-06-01 2

BORGSTROM MARNA P

  • Director
14,464 2020-06-01 2

HORTON AMY VP, CHIEF ACCOUNTING OFFICER

  • Officer
99,642 2020-05-28 6

LEE DAVID ASHLEY EXECUTIVE VP, COO & CFO

  • Officer
289,067 2020-05-22 6

CAPPS SCOTT B VP, CLINICAL RESEARCH

  • Officer
0 2020-05-05 6

MACKIN JAMES P PRESIDENT & CEO

  • Officer
0 2020-05-05 6

HOLLOWAY JEAN F VP, GENERAL COUNSEL

  • Officer
0 2020-05-05 9

DAVIS JOHN E SENIOR VP, GLOBAL SALES

  • Officer
0 2020-05-05 5

MAIER DENNIS B VICE PRESIDENT, OPERATIONS

  • Officer
0 2020-05-05 5

BOGENSCHUETZ THOMAS J VP, EMEA & GENERAL MANAGER

  • Officer
0 2020-05-05 3

SIMPSON MICHAEL S SVP, REGULATORY AFFAIRS AND QA

  • Officer
0 2020-05-05 4

GETZ MATTHEW A VP, HUMAN RESOURCES

  • Officer
0 2020-05-05 3

SAURINI SHERRY M VP, QUALITY

  • Officer
25,084 2019-03-14 0

MCDERMID JAMES M SVP, CHRO

  • Officer
30,806 2019-03-14 0

RONALD C ELKINS

  • Director
64,843 2018-09-05 0

MATTHEWS WILLIAM ROBERT SENIOR VP, OPERATIONS, QUALITY

  • Officer
39,883 2018-03-05 0

GALE DAVID C VP, RESEARCH & DEVELOPMENT

  • Officer
77,135 2017-11-16 0

BENSON JAMES

  • Director
54,086 2017-10-02 0

ANDERSON STEVEN G FORMER EXECUTIVE CHAIRMAN

  • Officer
No longer subject to file 2015-04-09 0

FRONK DAVID VP, REGULATORY AFFAIRS

  • Officer
110,559 2015-03-07 0

ANDERSON BRUCE G. VP, US SALES &GLOBAL MARKETING

  • Officer
104,096 2015-03-07 0

LANG DAVID P. VP, INT'L SALES & MARKETING

  • Officer
73,441 2015-02-26 0

BURRIS JEFFREY W VICE PRESIDENT & GEN. COUNSEL

  • Officer
95,221 2014-08-15 0

SEERY GERALD B SR. VP, SALES AND MARKETING

  • Officer
71,999 2012-11-30 0

HEACOX ALBERT E SR. VP RESEARCH AND DEVL

  • Officer
No longer subject to file 2011-12-31 0

COOK JOHN M

  • Director
104,500 2009-06-09 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

MCCALL RONALD D - Director

2020-06-01 A 5,667 $22.94 a 133,433 133,433.00 direct

ACKERMAN THOMAS F - Director

2020-06-01 A 5,667 $22.94 a 115,272 115,272.00 direct

BURBANK JEFFREY H - Director

2020-06-01 A 5,667 $22.94 a 19,172 19,172.00 direct

MORGAN HARVEY - Director

2020-06-01 A 5,667 $22.94 a 52,070 92,687.00 direct

BEVEVINO DANIEL J - Director

2020-06-01 A 5,667 $22.94 a 115,437 115,437.00 direct

BULLOCK JAMES - Director

2020-06-01 A 5,667 $22.94 a 24,023 24,023.00 direct

SALVESON JON W - Director

2020-06-01 A 5,667 $22.94 a 95,216 95,216.00 direct

BORGSTROM MARNA P - Director

2020-06-01 A 5,667 $22.94 a 14,464 14,464.00 direct

HORTON AMY - Officer VP, CHIEF ACCOUNTING OFFICER

2020-05-28 S 3,000 $23.81 d 99,642 99,642.00 direct

LEE DAVID ASHLEY - Officer EXECUTIVE VP, COO & CFO

2020-05-22 G 125 $22.86 d 282,567 289,067.00 direct

MCCALL RONALD D - Director

2020-05-05 A 1,620 a 129,485 129,485.00 direct

MAIER DENNIS B - Officer VICE PRESIDENT, OPERATIONS

2020-05-05 A 1,526 a 19,668 0.00 direct

HORTON AMY - Officer VP, CHIEF ACCOUNTING OFFICER

2020-05-05 A 1,611 a 102,642 0.00 direct

MCCALL RONALD D - Director

2020-05-05 S 1,719 $22.82 d 127,766 127,766.00 direct

DAVIS JOHN E - Officer SENIOR VP, GLOBAL SALES

2020-05-05 A 1,941 a 60,451 0.00 direct

ACKERMAN THOMAS F - Director

2020-05-05 A 1,455 a 109,605 109,605.00 direct

BULLOCK JAMES - Director

2020-05-05 A 1,289 a 18,356 18,356.00 direct

SIMPSON MICHAEL S - Officer SVP, REGULATORY AFFAIRS AND QA

2020-05-05 A 1,871 a 24,387 0.00 direct

LEE DAVID ASHLEY - Officer EXECUTIVE VP, COO & CFO

2020-05-05 A 2,421 a 282,692 6,500.00 direct

BOGENSCHUETZ THOMAS J - Officer VP, EMEA & GENERAL MANAGER

2020-05-05 A 877 a 23,451 0.00 direct

MORGAN HARVEY - Director

2020-05-05 A 1,620 a 46,403 87,020.00 direct

BEVEVINO DANIEL J - Director

2020-05-05 A 1,620 a 109,770 109,770.00 direct

BURBANK JEFFREY H - Director

2020-05-05 A 1,178 a 13,505 13,505.00 direct

GETZ MATTHEW A - Officer VP, HUMAN RESOURCES

2020-05-05 A 1,396 a 3,176 0.00 direct

HOLLOWAY JEAN F - Officer VP, GENERAL COUNSEL

2020-05-05 A 2,011 a 65,051 0.00 direct

MACKIN JAMES P - Officer PRESIDENT & CEO

2020-05-05 A 3,832 a 256,774 0.00 direct

CAPPS SCOTT B - Officer VP, CLINICAL RESEARCH

2020-05-05 A 1,797 a 147,006 0.00 direct

SALVESON JON W - Director

2020-05-05 A 1,399 a 89,549 89,549.00 direct

BORGSTROM MARNA P - Director

2020-05-05 A 1,178 a 8,797 8,797.00 direct

Elevate your investments